CAM
IDYA icon

Congress Asset Management’s IDEAYA Biosciences IDYA Stock Holding History

Congress Asset Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.67M Buy
147,696
+29,983
+25% +$1.13M 0.04% 259
2026
Q2 		$4.39M Buy
+117,713
New +$3.6M 0.03% 255

Other funds holding IDYA

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return

Congress Asset Management's IDYA Position: Q3 2026 in Review

Congress Asset Management increased its IDEAYA Biosciences (IDYA) stake by 25% in Q3 2026, buying an estimated $1.13M and bringing the position to 147,696 shares worth $5.67M. The position accounts for 0.04% of the portfolio, ranked #259.

Congress Asset Management first reported a position in IDYA in Q2 2026 and has held it in 2 quarters since. 7 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • Congress Asset Management held 147,696 shares of IDEAYA Biosciences worth $5.67M as of Q3 2026.
  • Congress Asset Management bought 29,983 IDEAYA Biosciences shares in Q3 2026, an estimated $1.13M.
  • IDEAYA Biosciences made up 0.04% of Congress Asset Management's portfolio in Q3 2026, its #259 holding.
  • Congress Asset Management first reported a position in IDEAYA Biosciences in Q2 2026 and has held it in 2 quarters since.
  • 7 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Congress Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.